Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing esomeprazole (a proton pump inhibitor - PPI) and amoxicillin and clarithromycin (antibiotics) used for the eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Primary Indications
Eradication of *Helicobacter pylori* in patients with active duodenal ulcer or gastric ulcer disease.
## Adult Dosing
The standard adult regimen is:
* Esomeprazole 20 mg orally twice daily
* Amoxicillin 1000 mg orally twice daily
* Clarithromycin 500 mg orally twice daily
This regimen is typically prescribed for 10 to 14 days.
## Pediatric Dosing
There is limited established pediatric dosing for Sompraz HP. Dosing should be based on weight and guided by pediatric gastroenterology and infectious disease specialists.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for esomeprazole or clarithromycin in mild to moderate renal impairment. Clarithromycin should be used with caution in severe renal impairment. Amoxicillin dose adjustment may be necessary in severe renal impairment (CrCl < 30 mL/min).
* **Hepatic Impairment:** Use with caution in severe hepatic impairment.
## Contraindications
* Known hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or other macrolides or penicillins.
* History of penicillin allergy.
* Concomitant use with cisapride, ergotamines, pimozide, or lovastatin/simvastatin due to potential for serious adverse events.
* Use in patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
## Adverse Effects
* **Common:** Diarrhea, nausea, abdominal pain, headache, taste disturbances, rash.
* **Serious:** *Clostridioides difficile*-associated diarrhea, severe hypersensitivity reactions (anaphylaxis), QT prolongation (clarithromycin), *C. difficile* colitis, *Stevens-Johnson syndrome/toxic epidermal necrolysis*, tendon rupture (associated with PPIs with prolonged use).
## Key Drug Interactions
* **Esomeprazole:** Can decrease the absorption of drugs that require acidic environments (e.g., ketoconazole, itraconazole, iron salts, vitamin B12). May increase serum concentrations of certain drugs metabolized by CYP2C19 (e.g., citalopram, diazepam) or CYP3A4 (e.g., warfarin, tacrolimus).
* **Clarithromycin:** Potent inhibitor of CYP3A4, can increase serum concentrations of numerous drugs (e.g., carbamazepine, cyclosporine, digoxin, some statins, theophylline, triazolam). May increase the risk of QT prolongation when used with other QT-prolonging agents. Avoid co-administration with colchicine in patients with renal or hepatic impairment.
* **Amoxicillin:** May decrease the effectiveness of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Monitor for gastrointestinal side effects, particularly diarrhea, to assess for *C. difficile* infection.
* If patients are on concomitant warfarin, monitor INR closely.
## Clinical Pearls
* Administer the PPI component at least 30 minutes before meals to maximize efficacy.
* Ensure the full course of antibiotics is completed to optimize eradication rates and minimize resistance.
* Consider resistance patterns in your geographic area for clarithromycin. If resistance is high, alternative regimens may be preferred.
* If a patient has a penicillin allergy, alternative *H. pylori* eradication regimens are necessary.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant literature for complete details regarding indications, contraindications, warnings, precautions, adverse reactions, and drug interactions before prescribing or administering any medication. Local protocols and guidelines may also apply.
